7459 — Medipal Holdings Share News
0.000.00%
- ¥530bn
- ¥385bn
- ¥4tn
Table: Medipal Holdings -2025/26 group results
Table: Medipal Holdings - 9-MTH group results
Brief: Medipal Holdings Corp - To Cancel 3,251,000 Shares Of Common Stock, Worth 1.48%, On Nov. 28
Table: Medipal Holdings - 6-MTH group results
Brief: Medipal Recieves Orphan Drug Designation For JR-446 For Mucopolysaccharidosis Type IIIB
Table: Medipal Holdings -Q1 group results
Brief: Medipal Holdings Announces European Commission Granted Orphan Drug Designation To JR-446
Brief: Medipal Holdings Corp - To Buy Back Up To 1.9% Of Own Shares Worth 8 Billion Yen
Table: Medipal Holdings -2024/25 group results
Table: Medipal Holdings -2024/25 parent results
Table: Medipal Holdings -2024/25 div forecast
Table: Medipal Holdings - 9-MTH group results
Brief: Medipal Holdings Corp - To Retire Treasury Shares Worth 0.93% Of Outstanding Stock On Sept 30
Table: Medipal Holdings -Q1 group results
Brief: JCR Pharmaceuticals Plans To Start Clinical Trial In Japan In First Half Of FY24
Brief: Medipal Holdings Corp - Announces Result Of Share Buyback For May 15-31
Brief: Medipal Holdings Corp - To Buy Back Up To 1.2% Of Own Shares Worth 5 Billion Yen
Table: Medipal Holdings -2023/24 parent results
Table: Medipal Holdings -2023/24 group results